Method and composition for treatment of erectile dysfunction

Details Method and composition for treatment of erectile dysfunction Method and composition for treatment of erectile dysfunction

A - Human Necessities

61

K

A61K 31/557 (2006.01)

Patent

CA 2295721

The invention relates to the treatment of impotence or erectile dysfunction by using prostaglandins that are selective EP2 or EP4 prostanoid receptor agonists. The prostaglandin medicaments can be formulated for intracavernous injection, or for transurethral or transdermal application.

L'invention concerne le traitement de l'absence d'érection ou de la dysérection au moyen de prostaglandines agissant comme des agonistes sélectifs vis-à-vis des récepteurs de prostanoïde EP¿2? ou EP¿4?. Il est possible d'établir des formulations de médicaments à base de prostaglandine aux fins d'injection dans le corps caverneux de la verge ou aux fins d'application transurétrale ou transdermique.

Affiliated with

Also associated with

Rating

Method and composition for treatment of erectile dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and composition for treatment of erectile dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treatment of erectile dysfunction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1452754